New drug combination shows promise for overcoming resistance in ovarian cancer
View as a Web Page
News Medical
 
  Oncology Oncology logo  
  The latest oncology news from News Medical  
 Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancerNovel antibody suppresses primary tumor growth and spread of triple-negative breast cancer
 
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with targeted therapies.
 
 
 New drug combination shows promise for overcoming resistance in ovarian cancerNew drug combination shows promise for overcoming resistance in ovarian cancer
 
Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope to ovarian cancer patients who do not respond to existing treatments.
 
   Integrating AI into colon cancer diagnosis improves the speed and accuracy of detectionIntegrating AI into colon cancer diagnosis improves the speed and accuracy of detection
 
A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has significantly improved the speed and accuracy of the detection of the deadly disease.
 
   Intravenous iron shows safe and beneficial outcomes for patients with bacterial infection and anemiaIntravenous iron shows safe and beneficial outcomes for patients with bacterial infection and anemia
 
Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with iron-deficiency anemia who were hospitalized for an acute bacterial infection, according to an analysis of data from more than 85,000 patients.
 
   Medical cannabis evidence falls short for most conditionsMedical cannabis evidence falls short for most conditions
 
Medical cannabis lacks adequate scientific backing for most of the conditions it is commonly used to treat, including chronic pain, anxiety and insomnia, according to a comprehensive review led by UCLA Health.
 
 Ultrasound can aid in treating vascular occlusion events from cosmetic filler injections
 
Ultrasound can aid in treating vascular occlusion events from cosmetic filler injectionsUltrasound can aid in treating complications from cosmetic filler injections, according to research being presented this week at the annual meeting of the Radiological Society of North America (RSNA).
 
 
 Chemotherapy-free combination treatment outperforms traditional regimens in patients with Ph+ ALL
 
Chemotherapy-free combination treatment outperforms traditional regimens in patients with Ph+ ALLA chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study.
 
 
 AI method could help clinicians accurately identify brain tumors and radiation necrosis
 
AI method could help clinicians accurately identify brain tumors and radiation necrosisWhile targeted radiation can be an effective treatment for brain tumors, subsequent potential necrosis of the treated areas can be hard to distinguish from the tumors on a standard MRI.
 
 
 Serious side effects after CAR T cell therapy for multiple myeloma share a common immune root cause
 
Serious side effects after CAR T cell therapy for multiple myeloma share a common immune root causeSerious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive CAR T cell therapy for multiple myeloma share a common immune root cause, are associated with high rates of death unrelated to cancer relapse-primarily infection-and may be avoidable.
 
 
 New investment aims to accelerate treatments for low-grade brain tumors
 
New investment aims to accelerate treatments for low-grade brain tumorsResearchers focused on accelerating and testing new treatments for low-grade brain tumors are set to receive a transformative £2.8 million to drive their future work.
 
 
 Lower dose of immunotherapy for malignant melanoma improves results
 
Lower dose of immunotherapy for malignant melanoma improves resultsAccording to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects.
 
 
 A personalized approach to treating pancreatic cancer
 
A personalized approach to treating pancreatic cancerIt's not surprising that pancreatic cancer is often referred to as a silent killer. With few early symptoms and an aggressive nature, it has one of the lowest survival rates of all cancers.
 
 
 Receiving immunotherapy earlier in the day may improve survival in cancer patients
 
Receiving immunotherapy earlier in the day may improve survival in cancer patientsReceiving anticancer immunotherapy earlier in the day may help individuals with cancer live longer. That's according to a study published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
 
 
 Study uncovers strategy to sensitize estrogen receptor–positive breast tumors to immunotherapy
 
Study uncovers strategy to sensitize estrogen receptor–positive breast tumors to immunotherapyA study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common tumor type, estrogen receptor-positive or luminal breast cancer.
 
 
 NeuMap unveils the hidden architecture and life-long patterns of human neutrophils
 
NeuMap unveils the hidden architecture and life-long patterns of human neutrophilsNeutrophils are the most abundant immune cells in the body and the first to respond to infection or tissue damage.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025